CN112301166A - Probe for detecting human papilloma virus HPV51 and kit thereof - Google Patents
Probe for detecting human papilloma virus HPV51 and kit thereof Download PDFInfo
- Publication number
- CN112301166A CN112301166A CN202011260475.6A CN202011260475A CN112301166A CN 112301166 A CN112301166 A CN 112301166A CN 202011260475 A CN202011260475 A CN 202011260475A CN 112301166 A CN112301166 A CN 112301166A
- Authority
- CN
- China
- Prior art keywords
- probe
- kit
- hpv
- dna
- library
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000701806 Human papillomavirus Species 0.000 title claims abstract description 81
- 239000000523 sample Substances 0.000 title claims abstract description 77
- 238000001514 detection method Methods 0.000 claims abstract description 22
- 239000011324 bead Substances 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 21
- 238000012408 PCR amplification Methods 0.000 claims description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims description 18
- 230000000903 blocking effect Effects 0.000 claims description 17
- 238000009396 hybridization Methods 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- 239000000872 buffer Substances 0.000 claims description 10
- 238000012165 high-throughput sequencing Methods 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 239000011534 wash buffer Substances 0.000 claims description 8
- 239000013642 negative control Substances 0.000 claims description 4
- 238000011002 quantification Methods 0.000 claims description 4
- 239000013641 positive control Substances 0.000 claims description 3
- 101100384865 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cot-1 gene Proteins 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- 238000007622 bioinformatic analysis Methods 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 238000011176 pooling Methods 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 35
- 230000010354 integration Effects 0.000 description 29
- 206010008342 Cervix carcinoma Diseases 0.000 description 23
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 23
- 201000010881 cervical cancer Diseases 0.000 description 23
- 238000012163 sequencing technique Methods 0.000 description 23
- 238000003752 polymerase chain reaction Methods 0.000 description 20
- 239000007853 buffer solution Substances 0.000 description 19
- 238000002156 mixing Methods 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000007788 liquid Substances 0.000 description 13
- 239000011259 mixed solution Substances 0.000 description 13
- 239000012634 fragment Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000013461 design Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000341655 Human papillomavirus type 16 Species 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 206010008263 Cervical dysplasia Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000003908 quality control method Methods 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- 208000009608 Papillomavirus Infections Diseases 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 239000013024 dilution buffer Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 241000264288 mixed libraries Species 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 2
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 101100343292 Arabidopsis thaliana LHT1 gene Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000009458 Carcinoma in Situ Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000007313 Reproductive Tract Infections Diseases 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000008696 hypoxemic pulmonary vasoconstriction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 238000001821 nucleic acid purification Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- XEBWQGVWTUSTLN-UHFFFAOYSA-M phenylmercury acetate Chemical compound CC(=O)O[Hg]C1=CC=CC=C1 XEBWQGVWTUSTLN-UHFFFAOYSA-M 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a probe for detecting human papillomavirus HPV51 and a kit thereof, wherein the probe group comprises a probe capable of specifically capturing HPV51 genome; the invention has the advantages of comprehensive detection range, greatly improved detection efficiency and accurate result.
Description
Technical Field:
The invention relates to a probe and a kit thereof, in particular to a probe and a kit for capturing and sequencing human papilloma virus HPV51 genes.
Background:
Cervical cancer refers to a malignant tumor that occurs in the cervix, vagina and cervix, and is one of the most common gynecological malignancies, second only to breast cancer. The cervical cancer is the second most serious cancer incidence and the third most serious mortality of women aged 15-44 in China. A large number of researches prove that the cervical cancer is mainly caused by continuous infection of high-risk Human Papilloma Virus (HPV), and the existence of high-risk HPV DNA is detected in 99.7 percent of cervical cancer patients. Currently, over 200 HPV genotypes have been identified, about 40 being associated with genital tract infections. The HPV is classified into high-risk types and low-risk types according to the high and low risk of causing cervical cancer, wherein the high-risk types comprise 13 genotypes such as HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 and the like which are classified as high-risk types, and 5 genotypes such as HPV 26, 53, 66, 73, 82 and the like which are classified as medium-risk types. These 18 types of HPV are primarily associated with the development of cervical intraepithelial neoplasia, CIN ii, iii and cervical cancer. The low risk forms are generally unrelated to malignant lesions, mainly causing condyloma acuminata and low grade cin (cini). Therefore, the detection of whether high-risk HPV infection exists in the exfoliated cervical cells and the periodic detection of whether persistent infection of HPV virus exists in the exfoliated cervical cells are particularly important in early screening, auxiliary diagnosis, post-cure evaluation and other links of cervical cancer.
Usually, HPV exists in a free state after infecting a host cell, and its DNA remains freely present in the cytoplasm of the host cell, and the HPV DNA is inserted into the human genome following replication by division of the host cell, a process also known as HPV integration. Once HPV DNA is accidentally integrated into the host cell chromosome, viral proteins will replicate disorderly, and the host cell genetic material structure and associated gene expression will change, resulting in uncontrolled division of the host cell, thereby inducing carcinogenesis. Although HPV DNA is detected in more than 99.7% of cervical cancers, not every patient infected with high-risk HPV develops cervical cancer. With the progress of molecular biology and cytogenetics, the integration of HPV with host chromosomes is an important step in the immortalization process of cervical cells, and is an important marker for the malignant progress of cervical intraepithelial neoplasia to cervical cancer. Integration of HPV with host cell chromosomes is found in more than 90% of cervical cancer tissues, and integration of HPV with host cell genomes is the most important risk factor for development of cervical cancer. Low risk HPV types rarely cause cervical cancer, independent of viral load in the host, because of their poor viral integration. The integration rates of high-risk HPV in HSIL and squamous cell carcinoma were 76.2% and 88.2%, respectively, and only 37% in LSIL. HPV exists in a non-free state in invasive cervical cancer (about 60.9%), which is 20% higher than that in situ cancer. HPV 16-positive cervical cancer cases are nearly 90% integrated, with only 16% of cases occurring in pure free form. The result shows that the incidence rate of virus integration is in positive correlation with the incidence rate of cervical cancer, and the virus integration state is in positive correlation with the disease degree of cervical cancer. The integration of HPV DNA and human genome can be used as a marker of cervical lesion degree, and has very important significance for early diagnosis of cervical cancer.
The early symptoms of the cervical cancer are not obvious, and the mortality rate caused by the cervical cancer can be effectively reduced only by early screening and early warning of the cervical cancer as soon as possible. Traditional pathological detection means, such as cervical smear detection, are easily influenced by factors such as material taking, staining and subjective judgment of cytopathologists, so that the application of cytopathology to detect HPV has the defects of low sensitivity, poor specificity, high false negative rate and false positive rate, incapability of typing HPV and the like. The current real-time fluorescence Polymerase Chain Reaction (PCR) method which is commonly used clinically has low detection flux, is difficult to meet the requirement of simultaneously detecting multiple types clinically for different types of HPV by respectively detecting different types of HPV, and is not suitable for large-scale screening of cervical cancer. More importantly, the methods used at present can only judge whether HPV infection exists or not and the type of HPV infection, and cannot judge whether HPV DNA is integrated with human genome, and an HPV integration event is an important factor for the generation of cervical cancer. The high-throughput sequencing technology (next-generation sequencing technology) has the advantages of accuracy, high sensitivity, rapidness and low cost, can simultaneously sequence a plurality of genes, and can realize HPV typing detection and HPV integration detection. The liquid phase hybridization gene capturing technology can enrich the relevant gene segments of the target area, and the cost of human gene sequencing, genetic research and gene diagnosis can be greatly reduced by combining a new generation gene sequencing technology, the sequencing depth is improved, and the variation information of the specific area is more accurately found. The design of the capture probe is the core of the liquid phase hybridization capture technology. In conclusion, the invention provides the probe set and the kit for detecting HPV typing and integration, which can accurately type 18 high-risk types of HPV at one time and determine the integration condition of the high-risk types of HPV in a human genome, have the advantages of high sensitivity and high specificity by processing a plurality of samples at one time, and have great clinical significance.
Disclosure of Invention:
The present invention is directed to solving the above-mentioned deficiencies of the prior art, and provides a capture probe set for detecting HPV and a kit thereof; the invention designs and synthesizes probe sequences according to the 18 HPV whole genome sequences, and carries out specific capture, amplification and sequencing on target fragments so as to achieve the purpose of detecting samples. The probe set comprises probes capable of specifically capturing all 18 HPV genomes. The method can comprehensively, quickly and accurately detect 18 HPV types and 5 HPV integration conditions, wherein the 18 HPV types are respectively HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73 and 82; the 5 HPV integrations were HPV16, 18, 33, 52, 58, respectively.
The invention adopts the following technical scheme:
the invention provides a probe for detecting typing and integration of human papillomavirus HPV51, and the probe information is shown in Table 1
The invention also provides a kit for detecting typing and integration of human papillomavirus HPV 51. The kit comprises the probe for detecting typing and integration of human papillomavirus HPV 51; preferably, the kit further comprises a library construction buffer solution 1, a library construction buffer solution 2, an enzyme 1, an enzyme 2, a joint, a PCR amplification primer 1, a PCR amplification primer 2, a PCR reaction mixed solution, a blocking sequence 1, a blocking sequence 2, a blocking reagent, a hybridization buffer solution, a PCR amplification primer 3, a PCR amplification reaction solution, a positive control, a negative control, a capture buffer solution, a cleaning buffer solution 1, a cleaning buffer solution 2 and a capture magnetic bead; preferably, the blocking sequence 1 is Cot-1 DNA, and the blocking sequence 2 is a double-stranded oligonucleotide.
Further, the components of the kit are shown in table 2.
The invention also discloses a method for using the probe for detecting typing and integration of human papillomavirus HPV51 and a kit thereof, which mainly comprises the following steps:
(1) design of capture probes for HPV51
(2) Sample DNA extraction, fragmentation and construction of DNA library
(3) Library target region targeted capture and quantitation
(4) High throughput sequencing
(5) Bioinformatic analysis of gene sequences
The invention provides a method for capturing HPV genes, which comprises the following specific capturing processes: extracting cervical exfoliated cell whole genome DNA, randomly breaking the cervical exfoliated cell whole genome DNA into fragments with the size of 200-300bp, and constructing a DNA library, wherein partial fragments contain HPV gene sequences; the HPV probe (carrying biotin label and capable of specifically hybridizing with the HPV DNA sequence) related by the invention is hybridized with the constructed pre-library, and the sequence containing HPV gene is combined with magnetic beads through biotin on the probe and can be specifically hybridized; washing away the HPV-free sequence to enrich the HPV gene fragments, so that the HPV sequence is captured by the kit; and (3) obtaining the HPV genotype of the sample to be detected and whether the sample to be detected is integrated with the human genome or not by sequencing the HPV in the sequencing result in a high-throughput manner by a sequencer Nextseq CN500 and analyzing the HPV information in the sequencing result.
The invention has the following beneficial effects:
(1) the invention designs a probe which can rapidly and accurately capture the complete sequence of the HPV51 genome and can effectively improve the detection specificity. The existing methods such as fluorescent quantitative PCR are only directed at a certain region of an HPV sequence, and the detection range of the probe can cover the whole HPV genome length.
(2) The invention utilizes HPV probes to sequence a library sample of a captured target region by utilizing a high-throughput sequencing technology. The HPV probes are used for carrying out targeted enrichment capture on the HPV sequences, and then high-throughput sequencing is carried out, so that the detection sensitivity is high.
(3) The invention can process a plurality of samples at one time, distinguish a plurality of different samples by adding different Barcodes, and then mix on-machine sequencing, thereby effectively improving the detection flux.
Drawings:
FIG. 1 shows the parameters of a PCR apparatus with a repaired end and an "A" reaction at the 3' end;
FIG. 2 shows the parameters of the Pre-PCR procedure.
The specific implementation mode is as follows:
the invention is further illustrated by the following examples. The reagents commonly used in the art for use in the present invention are commercially available, unless otherwise specified.
Example 1: design and preparation of Probe sets of the invention
Based on the base-complementary pairing principle, oligonucleotide probes complementary-paired with the HPV51 DNA sequence are designed. Due to the complex structure of genome sequences, irregular regions such as high GC and high AT regions exist, and due to the limitation of the read length of the second-generation sequencing, the design of probes becomes particularly critical, and various factors such as coverage rate, uniformity, capture efficiency and the like need to be comprehensively balanced. The specific principle of probe design is as follows:
(1) length: the selectable interval is 80-150bp, and 100bp is generally selected.
(2) The number of layers of the probes is as follows: i.e., how many probes are covered on average over the target area, 3 layers are generally suggested and a shingled design is required.
(3) Specificity: i.e., the uniqueness of the probe on the genome-wide scale, the higher the specificity, the higher the capture efficiency of the probe. Designing probes in low complexity regions should be avoided; however, in special cases, for example, where some hot spots happen to be located in a low complexity region, it is necessary to comprehensively evaluate the sequence of the region and adjacent regions, and carefully place probes.
(4) Binding capacity: the GC content is in a region of about 50%, and the probe capture capacity is strongest. The high GC area has strong probe binding capacity, but the DNA fragment has stronger self binding capacity (longer length) and larger probe competition resistance; since the high-AT region has a weak ability to bind to DNA fragments themselves, but also a weak ability to bind to probes, the number of probes needs to be increased appropriately in the high-GC and high-AT regions to compensate for the disadvantages in terms of competitive resistance and binding ability.
Preparing a probe: a large amount of designed probes are synthesized on a chip by a photochemical synthesis method, and then the biotin-labeled probes are obtained by PCR or transcription reaction.
Example 2: kit composition, preparation and use of the invention
The reagent kit for HPV detection described in this example.
The kit comprises the following components: the kit comprises a capture probe for detecting HPV, a library construction buffer solution 1, a library construction buffer solution 2, an enzyme 1, an enzyme 2, a joint, a PCR amplification primer 1, a PCR amplification primer 2, a PCR reaction mixed solution, a blocking sequence 1, a blocking sequence 2, a blocking reagent, a hybridization buffer solution, a PCR amplification primer 3, a PCR amplification reaction solution, a positive control, a negative control, a capture buffer solution, a cleaning buffer solution 1, a cleaning buffer solution 2 and a capture magnetic bead. The specific composition information is shown in table 2,
the using method of the kit comprises the following steps:
1. sample library preparation
(1) Fragmentation: 1000 ng of DNA is taken out, thawed, shaken and mixed evenly, water is added for supplementing to 100 mu L, and the mixture is interrupted by a Bioruptor Pico ultrasonic interrupting instrument. The specific parameters are set as follows: after the temperature of the cooling circulator is reduced to 4 ℃, setting parameters ON for 30 seconds, setting OFF for 30 seconds to be 1 cycle, setting one cycle for every 10 cycles, and performing 3 cycles in total; taking 1 mu L of sample to carry out fragment detection by using Qsep1, and detecting the main peak of the sample after normal fragmentation to be about 150 bp-200 bp.
(2) End repair plus a: and (3) performing end repair and adding ' A ' to the 3 ' end of the sample obtained in the last step. The specific reaction system is as follows: 35. mu.L of DNA fragment, 5. mu.L of ERA buffer, 10. mu.L of end repair enzyme. After mixing, run the PCR program and set the PCR instrument parameters as in FIG. 1 (50 μ L system, hot lid 85 ℃);
(3) adding a joint: and (4) performing joint connection on the sample obtained in the last step. The specific reaction system is as follows: 50 μ L of the sample after the reaction in the previous step, 5 μ L of linker, 15 μ L of enzyme-free water, 20 μ L of linking buffer, and 10 μ L of ligase; after mixing, run the PCR instrument program (without heat lid required), set the PCR instrument parameters: closing the hot cover, cooling to 20 ℃ for 30 minutes, and finishing the process
(4) Magnetic bead purification: immediately after the procedure is finished, the reaction product of the previous step is purified by using purified magnetic beads. The purification system was as follows: 100. mu.L of the reaction product of the previous step and 100. mu.L of purified magnetic beads.
(5) Pre-PCR amplification reaction: the purified product of the previous step is used as a template to carry out the Pre-PCR reaction. The specific reaction system is as follows: 20. mu.L of the purified product of the previous step, 25. mu.L of the PCR reaction mixture, 2.5. mu.L of PCR amplification reaction primer 1 (20. mu.M), and 2.5. mu.L of PCR amplification reaction primer 2 (20. mu.M). After mixing, the samples were placed on a PCR instrument and the PCR program was started as shown in FIG. 2 (50. mu.L system, hot lid temperature 105 ℃);
note: TPE1.0index number in the PCR amplification reaction primer 1 is 1# -8 # (Table 3); TPE2.0index number in the PCR amplification reaction primer 2 is 1# to 12 #; the index number used was recorded (table 4).
(6) Magnetic bead purification: immediately after the end of the procedure, the reaction product of the previous step was purified using 50. mu.L of purified magnetic beads.
2. Liquid phase hybridization of samples
(1) Standing and unfreezing the closed sequence 1 and the closed sequence 2 to prepare a mixed solution 1, which specifically comprises the following steps: 750ng library, 5. mu.L of blocking sequence 1, 2. mu.L of blocking sequence 2.
(2) And (3) taking out the blocking reagent and the probe in the kit, standing, thawing, shaking, uniformly mixing, and preparing a mixed solution 2 according to 5 mu L of the blocking reagent and 2 mu L of the probe (operation on ice).
(3) Taking out the hybridization buffer solution in the kit, placing the hybridization buffer solution at room temperature for thawing, taking out 20 mu L of the hybridization buffer solution after thawing, and placing the hybridization buffer solution in a constant temperature mixer at 65 ℃ for incubation for later use.
(4) Add 13. mu.L of hybridization buffer to mixture 2, blow and mix well, centrifuge briefly and collect the liquid, stand at room temperature for use.
(5) Using a temperature-controllable vacuum drier, setting the drying temperature at 45-50 ℃, opening a tube cover until the volume of the mixed solution 1 is concentrated to be less than 10 mu L, supplementing the mixed solution to 10 mu L with non-enzyme water, slightly sucking, uniformly mixing, centrifuging for a short time, and placing on ice for later use. The concentration time should not be too long to prevent evaporation.
(6) And placing the concentrated mixed solution 2 in a PCR instrument for incubation at 95 ℃ for 5min and at 65 ℃ for 2min (the temperature of a hot cover is 105 ℃), wherein the mixed solution does not need to be taken out after incubation is finished.
(7) The mixture 1 with the addition of hybridization buffer was incubated in a PCR apparatus at 65 ℃ for 2min (hot lid temperature 105 ℃).
(8) And (3) sucking 20 mu L of the mixed solution 1, adding into the mixed solution 2, fully and uniformly mixing, hybridizing for 16-24 h at 65 ℃, keeping the hybridization product in a PCR instrument, and entering a capturing step.
3. Capture
(1) And taking out the magnetic beads in the kit in advance, balancing the magnetic beads at room temperature for 30min, and shaking and uniformly mixing the magnetic beads.
(2) Remove 50. mu.L of magnetic beads into a new reaction tube, place the centrifuge tube on a magnetic rack, stand for 1min until the liquid is clear, and carefully aspirate the liquid (take care not to aspirate the magnetic beads).
(3) Adding 200 mu L of capture buffer solution into the magnetic beads, blowing and uniformly mixing, placing the centrifugal tube on a magnetic frame, standing for 1min until the liquid is clear, and carefully sucking away the liquid (not sucking the magnetic beads).
(4) Repeating the step (3) three times.
(5) And adding 200 mu L of capture buffer solution into the magnetic beads again to resuspend the magnetic beads, adding the resuspended magnetic beads into the hybridization products, and placing the PCR tube on a rotary vortex mixer to combine the magnetic beads at room temperature for 30 min.
(6) And taking out the washing buffer solution 1 and the washing buffer solution 2 in the kit, standing the washing buffer solution 1 at room temperature for later use, and preheating the washing buffer solution 2 at 65 ℃ for more than 5min for later use.
(7) The capture product was placed on a magnetic rack and allowed to stand for 1 minute for 1min until the liquid cleared, and the liquid was carefully aspirated (taking care not to attract the beads).
(8) The centrifuge tube was removed from the magnetic rack, 200. mu.L of washing buffer 1 was added, after pipetting and mixing, the tube was rotated on the mixer for 15min, placed on the magnetic rack and left to stand for 1min until the liquid was clear, and the liquid was carefully aspirated away (care was taken not to aspirate the beads).
(9) The centrifuge tube was removed from the magnetic rack, 200. mu.L of 65 ℃ preheated washing buffer 2 was added, after being blown and mixed well, placed on a constant temperature shaker (65 ℃, 800 rpm) for 10 minutes, placed on the magnetic rack and left for 1min until the liquid was clear, and the liquid was carefully discarded (care was taken not to attract the beads).
(10) Repeating the step (9) three times.
(11) Removing the centrifuge tube from the magnetic rack, adding 200 μ L of freshly prepared 80% ethanol, standing on the magnetic rack for 30sec until the liquid is clear, carefully aspirating the liquid (taking care not to aspirate the magnetic beads)
(12) The reaction tube is left on the upper magnetic frame and dried at room temperature for 3-5 min to volatilize the residual ethanol, and the surface of the magnetic bead is matt (excessive drying will cause the reduction of DNA yield).
(13) The centrifuge tube was removed from the magnetic frame, 30. mu.L of enzyme-free water was added, and the beads were resuspended for use.
(14) Preparing a mixed solution 3, using a 0.2mL PCR tube, and adopting a specific reaction system as follows: 18 mu of LPCR amplification buffer solution, 1 mu of LPCR amplification primer and 1 mu of LPCR amplification reaction solution.
(15) 20 μ L of the above reaction system was added to the washed product and mixed well.
(16) The PCR product was placed in a PCR apparatus to perform PCR amplification according to the reaction procedure shown in Table 5.
(17) And (3) purifying after amplification, and purifying an amplification product by using commercial nucleic acid purification magnetic beads, wherein the specific operation steps are carried out according to the instruction of a kit. Sucking all purified products, placing on ice, repeating the steps 2-3, and entering a sequencing stage or storing at-20 +/-5 ℃.
4. Quality control of captured libraries
(1) The concentration of the library is determined by using a nucleic acid quantitative Kit QubitdsDNA HS Assay Kit and a matched instrument, and the concentration of the library is more than 1 ng/. mu.L. Otherwise, the hybrid capture should be performed again.
(2) Taking a sample library or a reference library, and determining the size of the library fragment by using a Standard card Kit (S2) and a matched instrument, wherein the size of the library fragment should be concentrated between 250bp and 500bp, and no obvious small fragment and large fragment hybrid peak exists. Otherwise, the library sample is not qualified, and the hybridization capture is carried out again.
5. Library qPCR quantification
The on-machine enrichment Library was quantitated using the KAPA Library Quantification Kit to adjust to the appropriate on-machine concentration.
(1) Preparation of reagents: 1) preparing appropriate amount of DNA dilution buffer: 1XIDTE buffer was diluted to 0.1X using enzyme-free water, and approximately 1.2mL of dilution buffer was required for each library. The buffer was allowed to come to room temperature before use. 2) The components in the kit are unfrozen on ice, fully and uniformly mixed before use, centrifuged for a short time, and placed on ice for later use.
(2) Sample preparation: 1) appropriate dilutions of the library (using enzyme-free water) were prepared. Take 1 μ L enrichment library for 1: 100. 1: 10000. 1:20000 to dilute.
(3) Adding 8 mu L of mixed solution mixed with primers into each hole of a PCR reaction plate to be reacted, wherein the mixed solution specifically comprises the following components: mu.L of LMaster Mix, 1. mu.L of primer, 1.8. mu.L of water, 0.2. mu.L of LLow Rox.
(4) To each sample well was added the corresponding 2. mu.L of diluted DNA library (volume ratio 1:1000 and 1: 20000).
(5) To each well of the standard, 2. mu.L of each DNA standard was added in the order from low concentration to high concentration.
(6) To the negative control wells 2. mu.L of dilution buffer was added.
(7) The PCR reaction plate is sealed and put into a microplate centrifuge for centrifugation for 1 min.
(8) The reaction plate was loaded onto the qPCR instrument and the qPCR instrument was run according to the parameters of table 6 below.
(9) The concentration of the Library to be detected is calculated according to the KAPA Library Quantification Kit instruction. And if the final total molar mass of the library is less than 0.02p moles, performing hybrid enrichment on the library again or performing library building again, and if the final total molar mass of the library is unqualified again, terminating the detection.
6. Sequencing on machine
Sequencing was performed on a gene sequencer Nextseq CN500 using sequencing reagents with a sequencing read length of 300 cycles (Paired-End Reads, 2X 150 cycles), suggesting a sequencing data volume of 800M per sample library. The number of the sample libraries to be sequenced is not more than 48, and the NextSeq 500 Mid Output v2 Reagent kit (300 cycles) is recommended to be used for detection; the number of libraries of samples to be sequenced is higher than 48 and not higher than 96, and it is recommended that the NextSeq 500 High Output v2 Reagent kit (300 cycles) reagents be tested.
(1) Taking out Reagent Cartridge, HT1 and Flow Cell in advance, placing the Flow Cell in room temperature for balancing for 30min, placing the Reagent Cartridge in room temperature water bath for 1h, and placing HT1 in room temperature for standing, thawing, shaking and mixing uniformly.
(2) Mixing all sample libraries to be sequenced according to the sequencing data volume requirement, diluting the concentration of each library to 4 nM by using a nucleic acid quantitative Kit QubitdsDNA HS Assay Kit and a matched instrument, taking a new centrifugal tube with the same volume, taking each library for mixing, and enabling the total volume after mixing to be not less than 5 mu L.
(3) Prepare fresh 0.2N NaOH, add 1 μ L1N NaOH into 4 μ L purified water and mix to get final product.
(4) And (3) taking 5 mu L of the 4 nM mixed library to a new 1.5 mL centrifuge tube, adding 5 mu L of freshly prepared 0.2N NaOH, uniformly blowing, uniformly mixing, standing for 5min at room temperature for denaturation of the 4 nM mixed library, adding 990 mu LHT1 after uniformly mixing after denaturation, and diluting the mixed library to 20 pM.
(5) A new 1.5 mL centrifuge tube was added to the well-mixed 1365. mu.L of HT 1.
(6) 135. mu.L of the pooled library diluted to 20 pM was added to 1365. mu.L of HT1 to make the final on-machine pooled library volume 1500. mu.L.
(7) Taking out the Reagent card thawed in the room-temperature water bath, drying by using the dust-free paper sassafras, turning for 5 times, and uniformly mixing the reagents.
(8) Using a clean 1 mL pipette tip to puncture the 10-well foiling port with the Load Samples tag on the Reagent Cartridge, 1300 μ L of the final on-machine mix library mixed with the PhiX control was injected into the 10-well.
(9) And (3) carrying out reagent loading operation according to the running setting prompt of the sequencer, clicking a 'start' button to carry out sequencing after the self-checking of the sequencer is completed, and carrying out sequencing for 26-29 h.
7. HPV nucleic acid typing and integration biological information analysis process
(1) After the sequencing is completed, BCL2fastq v2.20.0.422 software of the illumina company is used for converting a BCL file generated by the sequencing into a fastq file corresponding to the sample.
(2) Reading record information of InterOp catalogues in a sequencing file by using illuminate v0.6 software, and performing quality analysis and evaluation on the sequencing. And quality control is carried out on Fastp v0.20.0, and the quality value of Q30 is required to be more than 80%.
(3) And after the quality evaluation is finished, preprocessing the data, and performing quality control on the original data according to the base and the quality of the fastq file (based on fastp v0.20.0 software).
(4) And (3) sequence alignment: alignment of the base sequences in the fastq file onto the human reference genome hg38 (GRCh 38) and the HPV genome generates a bam file (based on BWA v0.7.17, samtools v1.9 and picard v2.20.6 software: alignment).
(5) HPV type differential analysis: the number of reads and the proportion of the various HPVs in the sample were analyzed by sequence alignment files using a typing detection module (based on hpvHPKitTyper v1.0 software).
(6) HPV integration analysis: the HPV integration sites in the samples were analyzed and annotated in conjunction with the database by site comparison of the aligned HPV and human genome sequences in the alignment file using an integration detection module (based on hpkithvfusioncallerrv 1 software).
(7) And (4) judging a result: performing typing analysis, and judging that the single HPV type differential Mean depth is more than or equal to 10 as positive type; and (4) integration analysis, and if the number of HPV integration reads in the unit data volume is more than or equal to 3, judging that the type is integrated positively.
Example 3: verification of Using Effect of the kit of the present invention
The present invention will be described in further detail with reference to the following embodiments.
1. High throughput sequencing assay for HPV typing integration in 20 reference samples and 16 clinical samples
The sample numbers are S1-S36, wherein S1-S18 are typing plasmid reference substances of 10^4 copies/mL, HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73 and 82 respectively, S19 and S20 are SiHa cells (known HPV16 integrated sample) and HeLa cell DNA (known HPV18 integrated sample) with the concentration of 0.25 ng/muL respectively, and S21-S36 are clinical samples. And (3) detection results: the HPV type and the integration state corresponding to the reference sample are detected by using the method and the kit, which shows that the method and the kit can be used for accurately and rapidly detecting the actual sample and have practical use value. The probe set and the kit for HPV typing and integration detection provided by the invention have the characteristics of simple and convenient operation, high flux, good specificity, high sensitivity and the like. The results are as follows: table 7 shows the high-throughput sequencing quality control results of 36 samples, table 8 shows the high-throughput sequencing typing results of 36 samples, and table 9 shows the high-throughput sequencing integration results of 18 samples.
SEQUENCE LISTING
<110> Wuhan Kaideweis Biotech Co., Ltd
<120> a probe for detecting human papillomavirus HPV51 and a kit thereof
<130> 0
<160> 14
<170> PatentIn version 3.5
<210> 1
<211> 28398
<212> DNA
<213> Artificial Sequence
<220>
<223> Probe type HPV51
<400> 1
aacaattatc ttgtaaaaac tagggtgtaa ccgaaaaggg ttatgaccga aaacggtgca 60
tataaaagtg cagtggtaaa agtatagaag aacaccatgt cggtgcatat aaaagtgcag 120
tggtaaaagt atagaagaac accatgttcg aagacaagag ggaaagacca cgaacgctgc 180
atgaattatg tgaagctttg aagaacacca tgttcgaaga caagagggaa agaccacgaa 240
cgctgcatga attatgtgaa gctttgaacg tttctcgtaa caatatacag gtaagaacac 300
catgttcgaa gacaagaggg aaagaccacg aacgctgcat gaattatgtg aagctttgaa 360
cgtttctcgt aacaatatac aggtagtgtg tggggaaaga ccacgaacgc tgcatgaatt 420
atgtgaagct ttgaacgttt ctcgtaacaa tatacaggta gtgtgtgtgt attgtaaaaa 480
ggaccacgaa cgctgcatga attatgtgaa gctttgaacg tttctcgtaa caatatacag 540
gtagtgtgtg tgtattgtaa aaaggaatta tgtagagcag atgaacgttt ctcgtaacaa 600
tatacaggta gtgtgtgtgt attgtaaaaa ggaattatgt agagcagatg tatataatgt 660
agcatttact gaaattaaga ttgtagtgtg tgtgtattgt aaaaaggaat tatgtagagc 720
agatgtatat aatgtagcat ttactgaaat taagattgta tatagggata ataatccatc 780
gtagtgtatt gtaaaaagga attatgtaga gcagatgtat ataatgtagc atttactgaa 840
attaagattg tatataggga taataatcca tcgtaagtcg taagtatata atgtagcatt 900
tactgaaatt aagattgtat atagggataa taatccatcg taagtcgtaa aacaatgttt 960
actgttttat tcaaaaatta gaggtatata gggataataa tccatcgtaa gtcgtaaaac 1020
aatgtttact gttttattca aaaattagag agtatagacg ttatagcagg tctgtgtatg 1080
gtagcaaaca atgtttactg ttttattcaa aaattagaga gtatagacgt tatagcaggt 1140
ctgtgtatgg tactacatta gaggcaatta ctaaaaaaag cttaattaga gagtatagac 1200
gttatagcag gtctgtgtat ggtactacat tagaggcaat tactaaaaaa agcttatatg 1260
atttatcgat aaggtgtcat aggagtatag acgttatagc aggtctgtgt atggtactac 1320
attagaggca attactaaaa aaagcttata tgatttatcg ataaggtgtc atagatgtca 1380
aagtgtatgg tactacatta gaggcaatta ctaaaaaaag cttatatgat ttatcgataa 1440
ggtgtcatag atgtcaaaga ccacttgggc ctgaagaaaa gcactacatt agaggcaatt 1500
actaaaaaaa gcttatatga tttatcgata aggtgtcata gatgtcaaag accacttggg 1560
cctgaagaaa agcaaaaatt ggaaagctta tatgatttat cgataaggtg tcatagatgt 1620
caaagaccac ttgggcctga agaaaagcaa aaattggtgg acgaaaaaaa atgatttatc 1680
gataaggtgt catagatgtc aaagaccact tgggcctgaa gaaaagcaaa aattggtgga 1740
cgaaaaaaaa aggttccatg aaatagcggg agaccacttg ggcctgaaga aaagcaaaaa 1800
ttggtggacg aaaaaaaaag gttccatgaa atagcgggac gttggacggg gcacgtagct 1860
aattgctggc ggtggacgaa aaaaaaaggt tccatgaaat agcgggacgt tggacggggc 1920
acgtagctaa ttgctggcaa cgtacacgac aacgtaacga aacccaagtg aatagcggga 1980
cgttggacgg ggcacgtagc taattgctgg caacgtacac gacaacgtaa cgaaacccaa 2040
gtgtaataaa gcccgtagtg gtaatgtacc cgggacgttg gacggggcac gtagctaatt 2100
gctggcaacg tacacgacaa cgtaacgaaa cccaagtgta ataaagcccg tagtggtaat 2160
gtaccacaat gcaacgtaca cgacaacgta acgaaaccca agtgtaataa agcccgtagt 2220
ggtaatgtac cacaattaaa agatgtagta ttgcatttaa caccacagac cccaagtgta 2280
ataaagcccg tagtggtaat gtaccacaat taaaagatgt agtattgcat ttaacaccac 2340
agactgaaat tgacttgcac gtatacgagc taataaagcc cgtagtggta atgtaccaca 2400
attaaaagat gtagtattgc atttaacacc acagactgaa attgacttgc acgtatacga 2460
gcaatttgac aagatgtagt attgcattta acaccacaga ctgaaattga cttgcacgta 2520
tacgagcaat ttgacagctc agaggaggag gatgaagtag ataatcgtag agctcagagg 2580
aggaggatga agtagataat cgtagtgacc agctaccaga aagacgggct ggacaggcta 2640
cgtgttacag aattgaagct ccgtgttgca cgtgaccagc taccagaaag acgggctgga 2700
caggctacgt gttacagaat tgaagctccg tgttgcaggt gttcaagtgt agtacaactg 2760
gcagtggaaa ggacaggcta cgtgttacag aattgaagct ccgtgttgca ggtgttcaag 2820
tgtagtacaa ctggcagtgg aaagcagtgg agacaccctt cgcgctacgt gttacagaat 2880
tgaagctccg tgttgcaggt gttcaagtgt agtacaactg gcagtggaaa gcagtggaga 2940
cacccttcgc gttgtacagc agaaggtgtt caagtgtagt acaactggca gtggaaagca 3000
gtggagacac ccttcgcgtt gtacagcaga tgttaatggg cgaactaagc ctggtttgcc 3060
cgtaagcagt ggagacaccc ttcgcgttgt acagcagatg ttaatgggcg aactaagcct 3120
ggtttgcccg tgttgtgcga acaactagca acggcgatgg actatgttaa tgggcgaact 3180
aagcctggtt tgcccgtgtt gtgcgaacaa ctagcaacgg cgatggactg tgaaggtaca 3240
gaggatgagg gggcggggtg taacgtgttg tgcgaacaac tagcaacggc gatggactgt 3300
gaaggtacag aggatgaggg ggcggggtgt aatgggtggt tttttgttga agcaatagta 3360
gaatgtgaag gtacagagga tgagggggcg gggtgtaatg ggtggttttt tgttgaagca 3420
atagtagaaa aaaaaacagg agataatgtt tcggatgatg aggaatgggt ggttttttgt 3480
tgaagcaata gtagaaaaaa aaacaggaga taatgtttcg gatgatgagg atgaaacgta 3540
agatgataca ggatctgatt taaaaaaaac aggagataat gtttcggatg atgaggatga 3600
aacgtaagat gatacaggat ctgatttaat aaactttata gatagtgaaa ctagtatttg 3660
cagggatgaa acgtaagatg atacaggatc tgatttaata aactttatag atagtgaaac 3720
tagtatttgc agtcaggcgg aacaggagac agcacgggcg ttgtaaactt tatagatagt 3780
gaaactagta tttgcagtca ggcggaacag gagacagcac gggcgttgtt tcaggcccaa 3840
gaattacagg caaacaaaga ggctttgcag tcaggcggaa caggagacag cacgggcgtt 3900
gtttcaggcc caagaattac aggcaaacaa agaggctgtg catcagttaa aacgaaagtt 3960
tctcagtcag gcggaacagg agacagcacg ggcgttgttt caggcccaag aattacaggc 4020
aaacaaagag gctgtgcatc agttaaaacg aaagtttcta gtcgcgttgt ttcaggccca 4080
agaattacag gcaaacaaag aggctgtgca tcagttaaaa cgaaagtttc tagtcagccc 4140
gcgaagcagc ccattagttt caggcccaag aattacaggc aaacaaagag gctgtgcatc 4200
agttaaaacg aaagtttcta gtcagcccgc gaagcagccc attaggagac attacaggct 4260
gtgcatcagt taaaacgaaa gtttctagtc agcccgcgaa gcagcccatt aggagacatt 4320
acaaatcaaa acaacacaca cagccatagt caggcagccc gcgaagcagc ccattaggag 4380
acattacaaa tcaaaacaac acacacagcc atagtcaggc aaacgagtca caagttaaaa 4440
ggagattact ggacagaatc aaaacaacac acacagccat agtcaggcaa acgagtcaca 4500
agttaaaagg agattactgg acagttatcc ggacagcgga tatggcaata cacaagcgag 4560
tcacaagtta aaaggagatt actggacagt tatccggaca gcggatatgg caatacacaa 4620
gtggaaactg tggaagcaac gttgcaggta gatggggtta tccggacagc ggatatggca 4680
atacacaagt ggaaactgtg gaagcaacgt tgcaggtaga tgggcaacat ggcggttcac 4740
agaacagtgt gtgtaggtgg aaactgtgga agcaacgttg caggtagatg ggcaacatgg 4800
cggttcacag aacagtgtgt gtagtagcgg ggggggcagt gttatggatg tggaaagggc 4860
aacatggcgg ttcacagaac agtgtgtgta gtagcggggg gggcagtgtt atggatgtgg 4920
aaacaacaga aagctgtgca aatgtagaac taaacaagta gcgggggggg cagtgttatg 4980
gatgtggaaa caacagaaag ctgtgcaaat gtagaactaa acagtatatg tgaagtatta 5040
aaaagcagta cgtaaaacaa cagaaagctg tgcaaatgta gaactaaaca gtatatgtga 5100
agtattaaaa agcagtacgt aaaaagcaac gttaatggca aaatttaaag agttgtcagt 5160
atatgtgaag tattaaaaag cagtacgtaa aaagcaacgt taatggcaaa atttaaagag 5220
ttgtatggta ttagttataa tgagttggta cgggtgaaag caacgttaat ggcaaaattt 5280
aaagagttgt atggtattag ttataatgag ttggtacggg tgtttaaaag tgataaaaca 5340
tgttgtatag attgggatgg tattagttat aatgagttgg tacgggtgtt taaaagtgat 5400
aaaacatgtt gtatagattg ggtttgtgca ttgtttggcg tttccccaat ggtagctaaa 5460
agtgataaaa catgttgtat agattgggtt tgtgcattgt ttggcgtttc cccaatggta 5520
gcagaaaatt taaaaacact aattaagcca ttttgcaagt gataaaacat gttgtataga 5580
ttgggtttgt gcattgtttg gcgtttcccc aatggtagca gaaaatttaa aaacactaat 5640
taagccattt tgcatggttt gtgcattgtt tggcgtttcc ccaatggtag cagaaaattt 5700
aaaaacacta attaagccat tttgcatgta ctaccatata caatgtttat catgtggcag 5760
aaaatttaaa aacactaatt aagccatttt gcatgtacta ccatatacaa tgtttatcat 5820
gtgattgggg caccattgta ttacgtataa ttaggttgca tgtactacca tatacaatgt 5880
ttatcatgtg attggggcac cattgtatta cgtataatta ggttttcatg tgcaaaaaac 5940
agaacaacaa ttgctagatt ggggcaccat tgtattacgt ataattaggt tttcatgtgc 6000
aaaaaacaga acaacaattg ctaagtgttt aagtacatta gtaaatatcc cacaatggtt 6060
ttcatgtgca aaaaacagaa caacaattgc taagtgttta agtacattag taaatatccc 6120
acaatcacaa atgtttatag aaccaccaaa attacggtgc aaaaaacaga acaacaattg 6180
ctaagtgttt aagtacatta gtaaatatcc cacaatcaca aatgtttata gaaccaccaa 6240
aattacgtag tacaccgtgt ttaagtacat tagtaaatat cccacaatca caaatgttta 6300
tagaaccacc aaaattacgt agtacacctg tggcattata tttttataga acaggcgttt 6360
aagtacatta gtaaatatcc cacaatcaca aatgtttata gaaccaccaa aattacgtag 6420
tacacctgtg gcattatatt tttatagaac aggcatcaca aatgtttata gaaccaccaa 6480
aattacgtag tacacctgtg gcattatatt tttatagaac aggcatatca aacattagca 6540
atacatatgg agagacaaat gtttatagaa ccaccaaaat tacgtagtac acctgtggca 6600
ttatattttt atagaacagg catatcaaac attagcaata catatggagt acacctgtgg 6660
cattatattt ttatagaaca ggcatatcaa acattagcaa tacatatgga gagacacctg 6720
aatggattac acgacaaacg caactacggc atatcaaaca ttagcaatac atatggagag 6780
acacctgaat ggattacacg acaaacgcaa ctacaacata gttttgagga tagtaccttt 6840
gaattataca cctgaatgga ttacacgaca aacgcaacta caacatagtt ttgaggatag 6900
tacctttgaa ttatcacaaa tggtgcaatg ggcatttgac catgaagcaa catagttttg 6960
aggatagtac ctttgaatta tcacaaatgg tgcaatgggc atttgaccat gaagtattag 7020
atgatagtga aatagcattt cattatgcat agttttgagg atagtacctt tgaattatca 7080
caaatggtgc aatgggcatt tgaccatgaa gtattagatg atagtgaaat agcatttcat 7140
tcgtaaccac aaatggtgca atgggcattt gaccatgaag tattagatga tagtgaaata 7200
gcatttcatt cgtaacaatt agcagatata gatagtacgt atgcagcatg ggcatttgac 7260
catgaagtat tagatgatag tgaaatagca tttcattcgt aacaattagc agatatagat 7320
agtacgtatg cagcgttttt aaagtattag atgatagtga aatagcattt cattcgtaac 7380
aattagcaga tatagatagt acgtatgcag cgtttttaaa gagtaattgc caagcaaaat 7440
atgtagatga tagtgaaata gcatttcatt cgtaacaatt agcagatata gatagtacgt 7500
atgcagcgtt tttaaagagt aattgccaag caaaatatgt aagtgaaata gcatttcatt 7560
cgtaacaatt agcagatata gatagtacgt atgcagcgtt tttaaagagt aattgccaag 7620
caaaatatgt aaaagattgt ggcatttcat tcgtaacaat tagcagatat agatagtacg 7680
tatgcagcgt ttttaaagag taattgccaa gcaaaatatg taaaagattg tgggcacaat 7740
tagcagatat agatagtacg tatgcagcgt ttttaaagag taattgccaa gcaaaatatg 7800
taaaagattg tgggaccatg gcacggcatt acagcgtttt taaagagtaa ttgccaagca 7860
aaatatgtaa aagattgtgg gaccatggca cggcattaca aacgagcaca aagaaaatca 7920
ttatctatgt cagtttaaag agtaattgcc aagcaaaata tgtaaaagat tgtgggacca 7980
tggcacggca ttacaaacga gcacaaagaa aatcattatc tatgtcagcc tgggtaaaag 8040
attgtgggac catggcacgg cattacaaac gagcacaaag aaaatcatta tctatgtcag 8100
cctggataag gtatagatgt gatagagcaa aggcaaacga gcacaaagaa aatcattatc 8160
tatgtcagcc tggataaggt atagatgtga tagagcaaag gatggaggca actggagaga 8220
aattgctaaa tttgcctgga taaggtatag atgtgataga gcaaaggatg gaggcaactg 8280
gagagaaatt gctaaatttt taagatatca aggtgtaaac tttatgtcct ttagatggag 8340
gcaactggag agaaattgct aaatttttaa gatatcaagg tgtaaacttt atgtccttta 8400
ttcaaatgtt taaacagttt ttaaaaggaa cacaactgga gagaaattgc taaattttta 8460
agatatcaag gtgtaaactt tatgtccttt attcaaatgt ttaaacagtt tttaaaagga 8520
acaccataag atatcaaggt gtaaacttta tgtcctttat tcaaatgttt aaacagtttt 8580
taaaaggaac accaaaacac aattgcatag tcatatatgg cccaccattc aaatgtttaa 8640
acagttttta aaaggaacac caaaacacaa ttgcatagtc atatatggcc caccaaacac 8700
aggcaagtca ttatttgcaa tgagccccaa aacacaattg catagtcata tatggcccac 8760
caaacacagg caagtcatta tttgcaatga gcctaatgaa gtttcgtaaa gggtccatta 8820
tttcatccaa acacaggcaa gtcattattt gcaatgagcc taatgaagtt tcgtaaaggg 8880
tccattattt catatgtaaa ctctggtagt catttttggt tacagcctaa tgaagtttcg 8940
taaagggtcc attatttcat atgtaaactc tggtagtcat ttttggttac agccactaga 9000
ggcgtataaa atagcattgt tagatgtgca agggtccatt atttcatatg taaactctgg 9060
tagtcatttt tggttacagc cactagaggc gtataaaata gcattgttag atgcgtatat 9120
gtaaactctg gtagtcattt ttggttacag ccactagagg cgtataaaat agcattgtta 9180
gatgcgtata cgtatgggtg ttggacatat attgatcgcc actagaggcg tataaaatag 9240
cattgttaga tgcgtatacg tatgggtgtt ggacatatat tgatcagtat ttaagaaact 9300
ttttagatgg taatccatag aggcgtataa aatagcattg ttagatgcgt atacgtatgg 9360
gtgttggaca tatattgatc agtatttaag aaacttttta gatggtaatc catgtaggcg 9420
tatacgtatg ggtgttggac atatattgat cagtatttaa gaaacttttt agatggtaat 9480
ccatgtagta tagatagaaa acataggagt ttaataccag tatttaagaa actttttaga 9540
tggtaatcca tgtagtatag atagaaaaca taggagttta atacaattag tatgtccacc 9600
attactaata acgtcaatgt agtatagata gaaaacatag gagtttaata caattagtat 9660
gtccaccatt actaataacg tcaaacataa atccacaaga ggcgtaaaac ctaatgtcaa 9720
ttagtatgtc caccattact aataacgtca aacataaatc cacaagaggc gtaaaaccta 9780
atgtatttac atacaagggt aacagtatta aagttttaca taaatccaca agaggcgtaa 9840
aacctaatgt atttacatac aagggtaaca gtattaaagt ttttaaatac atttccattt 9900
gataacaatg ggacgtagta tttacataca agggtaacag tattaaagtt tttaaataca 9960
tttccatttg ataacaatgg gacgtatgtg tatacattga atgatgaaaa ttggaaatta 10020
aatacatttc catttgataa caatgggacg tatgtgtata cattgaatga tgaaaattgg 10080
aaaaattttt tttccaccac atggtccaga ttagattaaa tacatttcca tttgataaca 10140
atgggacgta tgtgtataca ttgaatgatg aaaattggaa aaattttttt tccaccacat 10200
ggtccagcat ttccatttga taacaatggg acgtatgtgt atacattgaa tgatgaaaat 10260
tggaaaaatt ttttttccac cacatggtcc agattagatt tggaggccat ttgataacaa 10320
tgggacgtat gtgtatacat tgaatgatga aaattggaaa aatttttttt ccaccacatg 10380
gtccagatta gatttggagg aggaatgatg aaaattggaa aaattttttt tccaccacat 10440
ggtccagatt agatttggag gaggaagagg acaaagaaaa tggagaccct atgattggaa 10500
aaattttttt tccaccacat ggtccagatt agatttggag gaggaagagg acaaagaaaa 10560
tggagaccct cgtacaccgt ttaaatgtgt gccttttttc caccacatgg tccagattag 10620
atttggagga ggaagaggac aaagaaaatg gagaccctcg tacaccgttt aaatgtgtgc 10680
caggagaaaa tacagattag atttggagga ggaagaggac aaagaaaatg gagaccctcg 10740
tacaccgttt aaatgtgtgc caggagaaaa tactagactg ttatgaactg gacaggagga 10800
agaggacaaa gaaaatggag accctcgtac accgtttaaa tgtgtgccag gagaaaatac 10860
tagactgtta tgaactggac agtgataaat tagaatggag accctcgtac accgtttaaa 10920
tgtgtgccag gagaaaatac tagactgtta tgaactggac agtgataaat tagtagatca 10980
aattaactat tggatactag actgttatga actggacagt gataaattag tagatcaaat 11040
taactattgg acattgttac gatatgaagc tgctatgttt tcgtaagcac gggttagtag 11100
atcaaattaa ctattggaca ttgttacgat atgaagctgc tatgttttcg taagcacggg 11160
aaagaaactt acgaacaatc aatcaccagg tagacgatat gaagctgcta tgttttcgta 11220
agcacgggaa agaaacttac gaacaatcaa tcaccaggta gtaccagcaa caacagtatc 11280
aaaacaaaag gcccgggaaa gaaacttacg aacaatcaat caccaggtag taccagcaac 11340
aacagtatca aaacaaaagg cctgtcaagc aattgaacgt aacatggcct tacagtacca 11400
gcaacaacag tatcaaaaca aaaggcctgt caagcaattg aacgtaacat ggccttacaa 11460
tcgcttaaca aatcagacta taacatggaa ccacagtatc aaaacaaaag gcctgtcaag 11520
caattgaacg taacatggcc ttacaatcgc ttaacaaatc agactataac atggaaccat 11580
ggactgtcaa gcaattgaac gtaacatggc cttacaatcg cttaacaaat cagactataa 11640
catggaacca tggacacgta gggagacatg ttatgaacta tggcaagcaa ttgaacgtaa 11700
catggcctta caatcgctta acaaatcaga ctataacatg gaaccatgga cacgtaggga 11760
gacatgttat gaactatggc gcttaacaaa tcagactata acatggaacc atggacacgt 11820
agggagacat gttatgaact atggtgtgtg gctcccaagc aatgtttcaa aaaggggggg 11880
gtgtgtggct cccaagcaat gtttcaaaaa ggggggcata actgtaacag ttatatttga 11940
tggaaataag gacacgtaaa tggactatac aagctggaag ggggcataac tgtaacagtt 12000
atatttgatg gaaataagga cacgtaaatg gactatacaa gctggaaatt tatatatata 12060
tatgataatg ataagtgggt aaggacacgt aaatggacta tacaagctgg aaatttatat 12120
atatatatga taatgataag tgggtaaaga caaatggaaa tgtggactat acgggtatat 12180
ttatatatat atatgataat gataagtggg taaagacaaa tggaaatgtg gactatacgg 12240
gtatatatta cactgtaaat tcaaaaaaag aatattatga gacaaatgga aatgtggact 12300
atacgggtat atattacact gtaaattcaa aaaaagaata ttatgtacag tttaaagatg 12360
aagccaaaat atatggggct attacactgt aaattcaaaa aaagaatatt atgtacagtt 12420
taaagatgaa gccaaaatat atggggcaca acagtgggag gtctatatgt atggtactgt 12480
gtacagttta aagatgaagc caaaatatat ggggcacaac agtgggaggt ctatatgtat 12540
ggtactgtaa taacatgtcc tgaatatgta tctagtacct ttaaagatga agccaaaata 12600
tatggggcac aacagtggga ggtctatatg tatggtactg taataacatg tcctgaatat 12660
gtatctagta cctgcagggg gcacaacagt gggaggtcta tatgtatggt actgtaataa 12720
catgtcctga atatgtatct agtacctgca gcgacgcgtt atccactact acaactgcaa 12780
cagtgggagg tctatatgta tggtactgta ataacatgtc ctgaatatgt atctagtacc 12840
tgcagcgacg cgttatccac tactacaact gttgaacgta ataacatgtc ctgaatatgt 12900
atctagtacc tgcagcgacg cgttatccac tactacaact gttgaacaac tatcaaacac 12960
cccaacgacc aatcccctgc agcgacgcgt tatccactac tacaactgtt gaacaactat 13020
caaacacccc aacgaccaat ccccttacca cctgcgtggg cgccaaagaa gcccagattg 13080
aacaactatc aaacacccca acgaccaatc cccttaccac ctgcgtgggc gccaaagaag 13140
cccagacaca acagcgaaaa cgacagcgac ttactgacct taccacctgc gtgggcgcca 13200
aagaagccca gacacaacag cgaaaacgac agcgacttac tgagcccgac tcctccacaa 13260
tctccccact gtccgtggac acaacagcga aaacgacagc gacttactga gcccgactcc 13320
tccacaatct ccccactgtc cgtggacaat acaaacaacc aaatacactg tggaagtcac 13380
aacagcgaaa acgacagcga cttactgagc ccgactcctc cacaatctcc ccactgtccg 13440
tggacaatac aaacaaccaa atacactgtg gaagtcccga ctcctccaca atctccccac 13500
tgtccgtgga caatacaaac aaccaaatac actgtggaag tggaagcact aacactggag 13560
ggcaccaaag tgcaaggaca atacaaacaa ccaaatacac tgtggaagtg gaagcactaa 13620
cactggaggg caccaaagtg caactcagac tgcgtttata gtgcatttaa aaggtgtgga 13680
agcactaaca ctggagggca ccaaagtgca actcagactg cgtttatagt gcatttaaaa 13740
ggtgatacaa attgtttaaa atgttttaga tacagaacac tggagggcac caaagtgcaa 13800
ctcagactgc gtttatagtg catttaaaag gtgatacaaa ttgtttaaaa tgttttagat 13860
acagatgcaa ctcagactgc gtttatagtg catttaaaag gtgatacaaa ttgtttaaaa 13920
tgttttagat acagatttac aaaacacaaa gggttatata aaaacgggtg atacaaattg 13980
tttaaaatgt tttagataca gatttacaaa acacaaaggg ttatataaaa acgtatcctc 14040
aacctggcat tggaccagta atactaacaa attgtttaaa atgttttaga tacagattta 14100
caaaacacaa agggttatat aaaaacgtat cctcaacctg gcattggacc agtaatacta 14160
aaagatttac aaaacacaaa gggttatata aaaacgtatc ctcaacctgg cattggacca 14220
gtaatactaa aacaggcatt gttaccattg tgtttgacag tgctcctcaa cctggcattg 14280
gaccagtaat actaaaacag gcattgttac cattgtgttt gacagtgcac atcaacggga 14340
aacatttata aaaaccatta aagaacaggc attgttacca ttgtgtttga cagtgcacat 14400
caacgggaaa catttataaa aaccattaaa gtacccccaa gtgtaacact gtcattggga 14460
attcacatca acgggaaaca tttataaaaa ccattaaagt acccccaagt gtaacactgt 14520
cattgggaat tatgacactg taactagtgt aatatatgta ttgagtaccc ccaagtgtaa 14580
cactgtcatt gggaattatg acactgtaac tagtgtaata tatgtattgt acatatatac 14640
tgtcacaagc caatatgtgc tgccaagtgt aacactgtca ttgggaatta tgacactgta 14700
actagtgtaa tatatgtatt gtacatatat actgtcacaa gccaatatgt gctgctaatt 14760
gtattatgac actgtaacta gtgtaatata tgtattgtac atatatactg tcacaagcca 14820
atatgtgctg ctaattgtat agacatattg taaccattgc agtggtacat atatactgtc 14880
acaagccaat atgtgctgct aattgtatag acatattgta accattgcag tgtttattat 14940
tttgctattt gtgctttgct tgtgagccaa tatgtgctgc taattgtata gacatattgt 15000
aaccattgca gtgtttatta ttttgctatt tgtgctttgc ttgtgtgtgt gtcttgtgtt 15060
ggctaattgt atagacatat tgtaaccatt gcagtgttta ttattttgct atttgtgctt 15120
tgcttgtgtg tgtgtcttgt gttgtgttgt ttgttgccgc tgtttattat tttgctattt 15180
gtgctttgct tgtgtgtgtg tcttgtgttg tgttgtttgt tgccgctact gctgtcccaa 15240
tacgtgtttg cagctgcctt agtgtgtgtc ttgtgttgtg ttgtttgttg ccgctactgc 15300
tgtcccaata cgtgtttgca gctgccttat tattaatttt atgtttttgg tttgttgttg 15360
cttgtgttgt gttgtttgtt gccgctactg ctgtcccaat acgtgtttgc agctgcctta 15420
ttattaattt tatgtttttg gtttgttgtt gcaacatcac tgctgtccca atacgtgttt 15480
gcagctgcct tattattaat tttatgtttt tggtttgttg ttgcaacatc ccaattaact 15540
acattttttg tatatttgtt attaatttta tgtttttggt ttgttgttgc aacatcccaa 15600
ttaactacat tttttgtata tttgattttt ttttacttac cttgtttact tttacatcca 15660
acatcccaat taactacatt ttttgtatat ttgatttttt tttacttacc ttgtttactt 15720
ttacatctat atacattttt acttttgcaa taaacttgga ttttttttta cttaccttgt 15780
ttacttttac atctatatac atttttactt ttgcaataaa cttgttatat ttttgtgatt 15840
aaatatggtg gctacacgtc tatatacatt tttacttttg caataaactt gttatatttt 15900
tgtgattaaa tatggtggct acacgtgcac ggcgtcggaa gcgagcatct gtaacacatt 15960
atatttttgt gattaaatat ggtggctaca cgtgcacggc gtcggaagcg agcatctgta 16020
acacaattat attctaccgt aaaagctgct ggtacatggt gcacggcgtc ggaagcgagc 16080
atctgtaaca caattatatt ctaccgtaaa agctgctggt acatgtcctc ctgatgttgt 16140
gaataaggtt gaaggtacca caattatatt ctaccgtaaa agctgctggt acatgtcctc 16200
ctgatgttgt gaataaggtt gaaggtacta cattggccga taaaatatta cagtggagat 16260
tatattctac cgtaaaagct gctggtacat gtcctcctga tgttgtgaat aaggttgaag 16320
gtactacatt ggccgataaa atattacagt ggagtggggt cctcctgatg ttgtgaataa 16380
ggttgaaggt actacattgg ccgataaaat attacagtgg agtgggttgg gtatattttt 16440
gggtggccta ggtattggaa taaggttgaa ggtactacat tggccgataa aatattacag 16500
tggagtgggt tgggtatatt tttgggtggc ctaggtattg gtactgggtc tgaataaggt 16560
tgaaggtact acattggccg ataaaatatt acagtggagt gggttgggta tatttttggg 16620
tggcctaggt attggtactg ggtctggcta cattggccga taaaatatta cagtggagtg 16680
ggttgggtat atttttgggt ggcctaggta ttggtactgg gtctggatct ggggggcgta 16740
ctggataggt tgggtatatt tttgggtggc ctaggtattg gtactgggtc tggatctggg 16800
gggcgtactg gatatatccc tttaggtggt gggggtcgcc caggcgttac tgggtctgga 16860
tctggggggc gtactggata tatcccttta ggtggtgggg gtcgcccagg cgtggtggat 16920
attgctcctg caaggccacc tattataata tccctttagg tggtgggggt cgcccaggcg 16980
tggtggatat tgctcctgca aggccaccta ttataattga cctatggcac catactgaac 17040
cttctatggt ggatattgct cctgcaaggc cacctattat aattgaccta tggcaccata 17100
ctgaaccttc tatagtaaat ttggttgagg actctagtat tattcagatt gacctatggc 17160
accatactga accttctata gtaaatttgg ttgaggactc tagtattatt cagtctgggt 17220
ctcctatacc tacctttact ggtaccgtag taaatttggt tgaggactct agtattattc 17280
agtctgggtc tcctatacct acctttactg gtaccgatgg ctttgaaatt acttcatctt 17340
ccacaacagt ctgggtctcc tatacctacc tttactggta ccgatggctt tgaaattact 17400
tcatcttcca caacaacccc tgctgtgttg gacatcaccc catctgcccg atggctttga 17460
aattacttca tcttccacaa caacccctgc tgtgttggac atcaccccat ctgctggtac 17520
tgtacatgtt tctagtacta acattgacaa cccctgctgt gttggacatc accccatctg 17580
ctggtactgt acatgtttct agtactaaca ttgaaaatcc tttatatatt gaacctccat 17640
ccattgacct gctgtgttgg acatcacccc atctgctggt actgtacatg tttctagtac 17700
taacattgaa aatcctttat atattgaacc tccatccatt gaggctcgct ggtactgtac 17760
atgtttctag tactaacatt gaaaatcctt tatatattga acctccatcc attgaggctc 17820
cacaatctgg agaagtgtca gatatatgaa aatcctttat atattgaacc tccatccatt 17880
gaggctccac aatctggaga agtgtcagat atatatttac tagtacacta ctctggtact 17940
catgggtgag gctccacaat ctggagaagt gtcagatata tatttactag tacactactc 18000
tggtactcat gggtatgaag aaatacctat ggaagtgttt gcatccaatt tactagtaca 18060
ctactctggt actcatgggt atgaagaaat acctatggaa gtgtttgcat ccaatgtcag 18120
tactggtact gaacctatta gcagcacgaa gaaataccta tggaagtgtt tgcatccaat 18180
gtcagtactg gtactgaacc tattagcagc acacctactc caggggttag tcgcatagct 18240
gctccccatg tcagtactgg tactgaacct attagcagca cacctactcc aggggttagt 18300
cgcatagctg ctccccgctt gtatagtaag tcctacacac aggttaacac ctactccagg 18360
ggttagtcgc atagctgctc cccgcttgta tagtaagtcc tacacacagg ttaaagttac 18420
aaatcctgat tttattagta agccatcccc cgcttgtata gtaagtccta cacacaggtt 18480
aaagttacaa atcctgattt tattagtaag ccatccacat ttgttacatt taataatcct 18540
gcttttgaag ttacaaatcc tgattttatt agtaagccat ccacatttgt tacatttaat 18600
aatcctgctt ttgagcctat tgacacatcc ataacttttg aggaacccca catttgttac 18660
atttaataat cctgcttttg agcctattga cacatccata acttttgagg aacctgcgta 18720
tgttgcacct gatcctgatt ttctggaagc ctattgacac atccataact tttgaggaac 18780
ctgcgtatgt tgcacctgat cctgattttc tggatattat tacactgcac cgccctgccc 18840
ttacatcctg cgtatgttgc acctgatcct gattttctgg atattattac actgcaccgc 18900
cctgccctta catctcgtag aggcacagta cgctttagta ggttaggata ttattacact 18960
gcaccgccct gcccttacat ctcgtagagg cacagtacgc tttagtaggt taggtcaaaa 19020
ggccacccgt agcactcgta gtggcaactc gtagaggcac agtacgcttt agtaggttag 19080
gtcaaaaggc cacccgtagc actcgtagtg gcaaacaaat tggtgctcgt gtacattatt 19140
atcatgacgt agaggcacag tacgctttag taggttaggt caaaaggcca cccgtagcac 19200
tcgtagtggc aaacaaattg gtgctcgtgt acattattat ggtcaaaagg ccacccgtag 19260
cactcgtagt ggcaaacaaa ttggtgctcg tgtacattat tatcatgata ttagtagaat 19320
tgcaccagct gatgggtcaa aaggccaccc gtagcactcg tagtggcaaa caaattggtg 19380
ctcgtgtaca ttattatcat gatattagta gaattgcacc agctgatgaa cttggtggca 19440
aacaaattgg tgctcgtgta cattattatc atgatattag tagaattgca ccagctgatg 19500
aacttgaacg taagccttta ctttcacctt ctaaacaaat tggtgctcgt gtacattatt 19560
atcatgatat tagtagaatt gcaccagctg atgaacttga acgtaagcct ttactttcac 19620
cttctaataa ttatatcatg atattagtag aattgcacca gctgatgaac ttgaacgtaa 19680
gcctttactt tcaccttcta ataattatag ttatgacatt tcgtatgatt atattagtag 19740
aattgcacca gctgatgaac ttgaacgtaa gcctttactt tcaccttcta ataattatag 19800
ttatgacatt tcgtatgatt tagatgaagc gaacttgaac gtaagccttt actttcacct 19860
tctaataatt atagttatga catttcgtat gatttagatg aagctgaaac aggttttata 19920
cagccaacgt aagcctttac tttcaccttc taataattat agttatgaca tttcgtatga 19980
tttagatgaa gctgaaacag gttttataca gcccacacac accacgttat gacatttcgt 20040
atgatttaga tgaagctgaa acaggtttta tacagcccac acacaccaca cctatgtcac 20100
actcctcttt gtctaggcag ttgcccacct atgtcacact cctctttgtc taggcagttg 20160
ccctccttat cttcatctat gtcttcatct tcgtaaaatg ttactattcc attttcaact 20220
acatatgccc tccttatctt catctatgtc ttcatcttcg taaaatgtta ctattccatt 20280
ttcaactaca tattctgttc ctattcatac agggcctgat gtggtcgtaa aatgttacta 20340
ttccattttc aactacatat tctgttccta ttcatacagg gcctgatgtg gtattgccca 20400
catctcctac agtatggcct tatgtattct gttcctattc atacagggcc tgatgtggta 20460
ttgcccacat ctcctacagt atggccttat gttccccaca cttccattga caccaagcat 20520
tctatattgc ccacatctcc tacagtatgg ccttatgttc cccacacttc cattgacacc 20580
aagcattcta ttgttatact aggtggggat tactatttgt ggcccttccc cacacttcca 20640
ttgacaccaa gcattctatt gttatactag gtggggatta ctatttgtgg ccctatacac 20700
atttactacg caaacgccgt aaacgattga caccaagcat tctattgtta tactaggtgg 20760
ggattactat ttgtggccct atacacattt actacgcaaa cgccgtaaac gtatacccta 20820
tttttgttat actaggtggg gattactatt tgtggcccta tacacattta ctacgcaaac 20880
gccgtaaacg tataccctat ttttttacag atggcattgt ggcgcgggga ttactatttg 20940
tggccctata cacatttact acgcaaacgc cgtaaacgta taccctattt ttttacagat 21000
ggcattgtgg cgcactaatg acagccctat acacatttac tacgcaaacg ccgtaaacgt 21060
ataccctatt tttttacaga tggcattgtg gcgcactaat gacagcaagg tgtatttgcc 21120
acctgtacgc aaacgccgta aacgtatacc ctattttttt acagatggca ttgtggcgca 21180
ctaatgacag caaggtgtat ttgccacctg cacctgtgtc cgtataccct atttttttac 21240
agatggcatt gtggcgcact aatgacagca aggtgtattt gccacctgca cctgtgtctc 21300
gaattgtgaa tacagaagaa cgcactaatg acagcaaggt gtatttgcca cctgcacctg 21360
tgtctcgaat tgtgaataca gaagaatata tcacacgcac cggcatatat tactcgtaag 21420
gcacctgtgt ctcgaattgt gaatacagaa gaatatatca cacgcaccgg catatattac 21480
tcgtaaggca gttccagact aataacatta ggacatccct atatcacacg caccggcata 21540
tattactcgt aaggcagttc cagactaata acattaggac atccctattt tccaatacct 21600
aaaacctcaa cgcgtgctgc ggcagttcca gactaataac attaggacat ccctattttc 21660
caatacctaa aacctcaacg cgtgctgcta ttcctaaagt atctgcattt caatacaggg 21720
ctattttcca atacctaaaa cctcaacgcg tgctgctatt cctaaagtat ctgcatttca 21780
atacagggta tttagggtac agttaccaga tcctaacaag gctattccta aagtatctgc 21840
atttcaatac agggtattta gggtacagtt accagatcct aacaagtttg gactcccgga 21900
tccaaattta tataatccag gtatttaggg tacagttacc agatcctaac aagtttggac 21960
tcccggatcc aaatttatat aatccagaca cagataggtt ggtgtggggt tgtgtgggcg 22020
tttggactcc cggatccaaa tttatataat ccagacacag ataggttggt gtggggttgt 22080
gtgggcgttg aggtgggcag aggacagccc cttggtgttg agacacagat aggttggtgt 22140
ggggttgtgt gggcgttgag gtgggcagag gacagcccct tggtgttggc cttagtggtc 22200
atcccttatt taataaatat cgttgaggtg ggcagaggac agccccttgg tgttggcctt 22260
agtggtcatc ccttatttaa taaatatgat gacacagaaa attcacgcat agcaaatggc 22320
ggccttagtg gtcatccctt atttaataaa tatgatgaca cagaaaattc acgcatagca 22380
aatggcacgt aacaacaaga tgttagagat aacacatctg gatgacacag aaaattcacg 22440
catagcaaat ggcacgtaac aacaagatgt tagagataac acatctgttg acaacaaaca 22500
gactcagtta tgtataatag gcacgtaaca acaagatgtt agagataaca catctgttga 22560
caacaaacag actcagttat gtataatagg ctgtgctcca cctattgggg aacactgggg 22620
gttgacaaca aacagactca gttatgtata ataggctgtg ctccacctat tggggaacac 22680
tggggtattg gcactaccgt aaaaaacaca cctgtacctc ggctgtgctc cacctattgg 22740
ggaacactgg ggtattggca ctaccgtaaa aaacacacct gtacctccag gagactgccc 22800
ccccctggaa cttgtatcct ttggcactac cgtaaaaaac acacctgtac ctccaggaga 22860
ctgccccccc ctggaacttg tatcctctgt cattcaggat ggcgatatga ttgatacagg 22920
tccaggagac tgcccccccc tggaacttgt atcctctgtc attcaggatg gcgatatgat 22980
tgatacaggg tttggagcta tggatttcgc tgccctacag tctgtcattc aggatggcga 23040
tatgattgat acagggtttg gagctatgga tttcgctgcc ctacaggcca ccaaatcaga 23100
cgtccctttg gatatttcac cagggtttgg agctatggat ttcgctgccc tacaggccac 23160
caaatcagac gtccctttgg atatttcaca gtctgtttgt aaatatcctg attatttaag 23220
ggtttggagc tatggatttc gctgccctac aggccaccaa atcagacgtc cctttggata 23280
tttcacagtc tgtttgtaaa tatcctgatt atttaaaaag gccaccaaat cagacgtccc 23340
tttggatatt tcacagtctg tttgtaaata tcctgattat ttaaaaatgt ctgcagacac 23400
atatggtaat tccatgtttc agtctgtttg taaatatcct gattatttaa aaatgtctgc 23460
agacacatat ggtaattcca tgttttttca tttacgcagg gagcaaatct ttgctaggca 23520
tcctgattat ttaaaaatgt ctgcagacac atatggtaat tccatgtttt ttcatttacg 23580
cagggagcaa atctttgcta ggcactatta taataaatgt ctgcagacac atatggtaat 23640
tccatgtttt ttcatttacg cagggagcaa atctttgcta ggcactatta taataaactt 23700
gtaggtgttg gggaagttca tttacgcagg gagcaaatct ttgctaggca ctattataat 23760
aaacttgtag gtgttgggga agacattcct aacgattatt atattaaggg tagtgggaca 23820
ttcctaacga ttattatatt aagggtagtg gtaatggccg tgaccctata gaaagttata 23880
tatactctgc tactcccagt gggtctatga taacatggta atggccgtga ccctatagaa 23940
agttatatat actctgctac tcccagtggg tctatgataa catctgattc tcaaattttt 24000
aataagcctt attggcctct gctactccca gtgggtctat gataacatct gattctcaaa 24060
tttttaataa gccttattgg ctccaccgtg cgcagggtca caataatggc atttgccagt 24120
gggtctatga taacatctga ttctcaaatt tttaataagc cttattggct ccaccgtgcg 24180
cagggtcaca ataatggcat ttgctggaac aatcagtctg attctcaaat ttttaataag 24240
ccttattggc tccaccgtgc gcagggtcac aataatggca tttgctggaa caatcagctt 24300
tttattacct gtgttgtttt aataagcctt attggctcca ccgtgcgcag ggtcacaata 24360
atggcatttg ctggaacaat cagcttttta ttacctgtgt tgatactacg ctccaccgtg 24420
cgcagggtca caataatggc atttgctgga acaatcagct ttttattacc tgtgttgata 24480
ctaccagaag tacaaattta actattagcg ggtcacaata atggcatttg ctggaacaat 24540
cagcttttta ttacctgtgt tgatactacc agaagtacaa atttaactat tagcactgcg 24600
ctggaacaat cagcttttta ttacctgtgt tgatactacc agaagtacaa atttaactat 24660
tagcactgcc actgctgcgg tttccccaac atttactccg atactaccag aagtacaaat 24720
ttaactatta gcactgccac tgctgcggtt tccccaacat ttactccaag taactttaag 24780
caatatatta ggcatggggg cactgccact gctgcggttt ccccaacatt tactccaagt 24840
aactttaagc aatatattag gcatggggaa gagtatgaat tgcaatttat ttttcaattc 24900
caagtaactt taagcaatat attaggcatg gggaagagta tgaattgcaa tttatttttc 24960
aattatgtaa aattacttta actacagagg taatggcttg aagagtatga attgcaattt 25020
atttttcaat tatgtaaaat tactttaact acagaggtaa tggcttattt acacacaatg 25080
gatcctacca ttcttgaacg taaaattact ttaactacag aggtaatggc ttatttacac 25140
acaatggatc ctaccattct tgaacagtgg aattttggat taacattacc tccgtctgct 25200
atttacacac aatggatcct accattcttg aacagtggaa ttttggatta acattacctc 25260
cgtctgctag tttggaggcg taatataggt ttgttagaac agtggaattt tggattaaca 25320
ttacctccgt ctgctagttt ggaggcgtaa tataggtttg ttagaacgta agctactagc 25380
tgtcaaaagg acacccctcg gattaacatt acctccgtct gctagtttgg aggcgtaata 25440
taggtttgtt agaacgtaag ctactagctg tcaaaaggac acccctccac aggctaagct 25500
agtttggagg cgtaatatag gtttgttaga acgtaagcta ctagctgtca aaaggacacc 25560
cctccacagg ctaagccaga tcctttggcc aaatatacgt aagctactag ctgtcaaaag 25620
gacacccctc cacaggctaa gccagatcct ttggccaaat ataaattttg ggatgttgat 25680
ttaaaggaac gattttccca caggctaagc cagatccttt ggccaaatat aaattttggg 25740
atgttgattt aaaggaacga ttttctttag atttagacca atttgcattg ggtcgcaatt 25800
ttgggatgtt gatttaaagg aacgattttc tttagattta gaccaatttg cattgggtcg 25860
caagtttttg ttgcaggttg gcgtacaacg caagcccaag tttttgttgc aggttggcgt 25920
acaacgcaag cccagaccag gccttaaacg cccggcctca tcggcatcct cttcctcttc 25980
ctcttcagcc aaacgtaccc agaccaggcc ttaaacgccc ggcctcatcg gcatcctctt 26040
cctcttcctc ttcagccaaa cgtaaacgtg ttaaaaagta atgtatgtta gtttttgggc 26100
atcctcttcc tcttcctctt cagccaaacg taaacgtgtt aaaaagtaat gtatgttagt 26160
ttttgtcgta ttgtgcacac tgttgtcgta ctgtatgaac gtgttaaaaa gtaatgtatg 26220
ttagtttttg tcgtattgtg cacactgttg tcgtactgta tgtatatgtt tgtgtatgta 26280
ctgtatgtgt ttttgtggtc gtattgtgca cactgttgtc gtactgtatg tatatgtttg 26340
tgtatgtact gtatgtgttt ttgtgtgtgt gtgtgttgtt gttcctgtat gtatgagata 26400
tgtttgtgta tgtactgtat gtgtttttgt gtgtgtgtgt gttgttgttc ctgtatgtat 26460
gagttatgta tgtttattat taataaacta tgtggtgtgt gtgtgtgtgt tgttgttcct 26520
gtatgtatga gttatgtatg tttattatta ataaactatg tggtgtgtgt gtgtgtgttt 26580
ttgcatgact gcatttggtt atgtatgttt attattaata aactatgtgg tgtgtgtgtg 26640
tgtgtttttg catgactgca tttgtatgac atgtacgggt gtatgtgggt attacatgtg 26700
tgtgtgtgtg tttttgcatg actgcatttg tatgacatgt acgggtgtat gtgggtatta 26760
cattatcccc gtaggtcaag ggtggtgttt cggtggcgtg tgtgtgtttt tgcatgactg 26820
catttgtatg acatgtacgg gtgtatgtgg gtattacatt atccccgtag gtcaagggtg 26880
gtgtttcggt ggcgtcccgt atgacatgta cgggtgtatg tgggtattac attatccccg 26940
taggtcaagg gtggtgtttc ggtggcgtcc ctattgccct acccattttt tgcagcactt 27000
atccccgtag gtcaagggtg gtgtttcggt ggcgtcccta ttgccctacc cattttttgc 27060
agcacaacag tttatatttg tgctatttag ttatacttgg cgtccctatt gccctaccca 27120
ttttttgcag cacaacagtt tatatttgtg ctatttagtt atactttgta gcttccattt 27180
tgttacagct gcagccatca acagtttata tttgtgctat ttagttatac tttgtagctt 27240
ccattttgtt acagctgcag ccattttgag tgcaaccgat ttcggttcgt gtactttttt 27300
gtagcttcca ttttgttaca gctgcagcca ttttgagtgc aaccgatttc ggttcgtgta 27360
cttttagtat atttgccaag ttttaaacca caactgcctt gagtgcaacc gatttcggtt 27420
cgtgtacttt tagtatattt gccaagtttt aaaccacaac tgccagttgt ttttggcata 27480
aaccatcatt tttttatgag tatatttgcc aagttttaaa ccacaactgc cagttgtttt 27540
tggcataaac catcattttt ttatgacata gtgcatacat ccgcccgccc acgccttgca 27600
gttgtttttg gcataaacca tcattttttt atgacatagt gcatacatcc gcccgcccac 27660
gccttgtact tggcgcgcct taccggcgct agtcatacga catagtgcat acatccgccc 27720
gcccacgcct tgtacttggc gcgccttacc ggcgctagtc atacaaccta ttagtcattt 27780
gtactttaac aattgttgtg tacttggcgc gccttaccgg cgctagtcat acaacctatt 27840
agtcatttgt actttaacaa ttgttggcac actgttttcc gccctataat aatttaacca 27900
acctattagt catttgtact ttaacaattg ttggcacact gttttccgcc ctataataat 27960
ttaactgctt ataggcatgt attttttggc atattttatg gcacactgtt ttccgcccta 28020
taataattta actgcttata ggcatgtatt ttttggcata ttttatctta ctaattgcat 28080
agttggcagg tcaaatacct gcttataggc atgtattttt tggcatattt tatcttacta 28140
attgcatagt tggcaggtca aatactatgt ttttagtgcc aagtttctat cctacttatc 28200
ttactaattg catagttggc aggtcaaata ctatgttttt agtgccaagt ttctatccta 28260
cttataaacc atcttactca tcgtaaggtg tgctacacct atgtttttag tgccaagttt 28320
ctatcctact tataaaccat cttactcatc gtaaggtgtg ctacacaaat gtgttaccta 28380
accgatttgt gttctgcc 28398
<210> 2
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 2
caagcagaag acggcatacg agattgcatg acgtgactgg agttcagacg tgt 53
<210> 3
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 3
caagcagaag acggcatacg agattgctat cggtgactgg agttcagacg tgt 53
<210> 4
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 4
caagcagaag acggcatacg agatcacaag cagtgactgg agttcagacg tgt 53
<210> 5
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 5
caagcagaag acggcatacg agattcgctg atgtgactgg agttcagacg tgt 53
<210> 6
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 6
caagcagaag acggcatacg agatcgcttt gtgtgactgg agttcagacg tgt 53
<210> 7
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 7
caagcagaag acggcatacg agatccgatg aagtgactgg agttcagacg tgt 53
<210> 8
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 8
caagcagaag acggcatacg agattgacca cagtgactgg agttcagacg tgt 53
<210> 9
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 9
caagcagaag acggcatacg agatgaagcc atgtgactgg agttcagacg tgt 53
<210> 10
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 10
caagcagaag acggcatacg agatttctgg tggtgactgg agttcagacg tgt 53
<210> 11
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 11
caagcagaag acggcatacg agatccgaaa acgtgactgg agttcagacg tgt 53
<210> 12
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 12
caagcagaag acggcatacg agatcgaaaa gggtgactgg agttcagacg tgt 53
<210> 13
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> primer
<400> 13
caagcagaag acggcatacg agataaccag ctgtgactgg agttcagacg tgt 53
<210> 14
<211> 60
<212> DNA
<213> Artificial Sequence
<220>
<223> joint
<400> 14
ctacaataat tcatgtataa aactaagggc tagtataaaa gcagacattt tcgtaaccaa 60
Claims (7)
1. A probe for detecting human papillomavirus HPV51, characterized by comprising the following probes: SEQ ID NO. 1.
2. A kit for detecting human papillomavirus HPV51, characterized in that it comprises the probe of claim 1.
3. The kit of claim 2, wherein the kit further comprises a pooling buffer 1, a pooling buffer 2, an enzyme 1, an enzyme 2, a linker, a PCR amplification primer 1, a PCR amplification primer 2, a PCR reaction mixture, a blocking sequence 1, a blocking sequence 2, a blocking reagent, a hybridization buffer, a PCR amplification primer 3, a PCR amplification reaction, a positive control, a negative control, a capture buffer, a wash buffer 1, a wash buffer 2, and capture magnetic beads.
4. The kit according to claim 3, wherein the blocking sequence 1 is Cot-1 DNA.
5. The kit of claim 4, wherein the blocking sequence 2 is a double-stranded oligonucleotide.
6. A method for detecting human papillomavirus HPV51 using the probe of claim 1, characterized in that it comprises the following steps:
(1) extracting sample DNA, fragmenting, constructing a DNA library,
(2) hybridizing the probe of claim 1 with the library to perform target capture and quantification of the target region,
(3) and a high-throughput sequencing method,
(4) and bioinformatic analysis of gene sequences.
7. The use of the probe of claim 1 for human papillomavirus HPV detection of non-diagnostic non-therapeutic interest.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011260475.6A CN112301166A (en) | 2020-11-12 | 2020-11-12 | Probe for detecting human papilloma virus HPV51 and kit thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011260475.6A CN112301166A (en) | 2020-11-12 | 2020-11-12 | Probe for detecting human papilloma virus HPV51 and kit thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112301166A true CN112301166A (en) | 2021-02-02 |
Family
ID=74325862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011260475.6A Pending CN112301166A (en) | 2020-11-12 | 2020-11-12 | Probe for detecting human papilloma virus HPV51 and kit thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112301166A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104450885A (en) * | 2014-10-29 | 2015-03-25 | 百世诺(北京)医疗科技有限公司 | Kit for detecting neurofibromatosis 1 (NF1)-related gene mutation |
US20160010163A1 (en) * | 2013-03-01 | 2016-01-14 | The Johns Hopkins University | Dual sequence-capture method for quantifying trans renal hpv dna in urine |
CN107739761A (en) * | 2016-08-12 | 2018-02-27 | 嘉兴允英医学检验有限公司 | It is a kind of to be used for HPV partings and the high-flux sequence detection method of integration |
-
2020
- 2020-11-12 CN CN202011260475.6A patent/CN112301166A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160010163A1 (en) * | 2013-03-01 | 2016-01-14 | The Johns Hopkins University | Dual sequence-capture method for quantifying trans renal hpv dna in urine |
CN104450885A (en) * | 2014-10-29 | 2015-03-25 | 百世诺(北京)医疗科技有限公司 | Kit for detecting neurofibromatosis 1 (NF1)-related gene mutation |
CN107739761A (en) * | 2016-08-12 | 2018-02-27 | 嘉兴允英医学检验有限公司 | It is a kind of to be used for HPV partings and the high-flux sequence detection method of integration |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110423844B (en) | Methods and compositions for detecting BK virus | |
WO2022100444A1 (en) | Probe set for human papillomavirus (hpv) typing and integration detection and kit thereof | |
CN110853708B (en) | Design method of nucleic acid capture probe for HLA typing | |
WO2014079350A1 (en) | Cho cell dna detection method | |
CN112662760A (en) | Cancer gene methylation detection system and cancer in-vitro detection method implemented in cancer gene methylation detection system | |
CN112266983B (en) | Probe set for detecting human papilloma viruses HPV16 and HPV18 and kit thereof | |
CN108192965B (en) | Method for detecting heterogeneity of mitochondrial genome A3243G locus | |
CN112662762A (en) | Probe composition for detecting 5 tumors of digestive tract | |
KR101761701B1 (en) | HPV Specific Probe and DNA Chip for Detecting Genetic Type of HPV Containing Thereof | |
CN104928399A (en) | Primer group, kit and use thereof in HPV whole-genome detection | |
CN110819715A (en) | Immune gene marker and kit for colorectal cancer detection | |
CN112195286B (en) | Probe for detecting human papilloma virus HPV26 and kit thereof | |
CN112301166A (en) | Probe for detecting human papilloma virus HPV51 and kit thereof | |
CN112195281A (en) | Probe for detecting human papilloma virus HPV56 and kit thereof | |
CN110600082B (en) | Nucleic acid capture probe for HLA typing and design method thereof | |
CN112195280B (en) | Probe for detecting human papilloma virus HPV39 and kit thereof | |
CN112195283A (en) | Probe for detecting human papilloma virus HPV31 and kit thereof | |
CN112195282A (en) | Probe for detecting human papilloma virus HPV35 and kit thereof | |
CN112266982A (en) | Probe for detecting human papilloma virus HPV45 and kit thereof | |
CN112266981A (en) | Probe for detecting human papilloma virus HPV68 and kit thereof | |
CN112522439B (en) | Probe set for detecting HPV (human papilloma Virus) typing and integration of 5 human papilloma viruses and kit thereof | |
CN112195279A (en) | Probe for detecting human papilloma virus HPV59 and kit thereof | |
CN112195284A (en) | Probe for detecting human papilloma virus HPV73 and kit thereof | |
CN112301164A (en) | Probe for detecting human papilloma virus HPV66 and kit thereof | |
CN112301165A (en) | Probe for detecting human papilloma virus HPV82 and kit thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210202 |
|
WD01 | Invention patent application deemed withdrawn after publication |